Clinical Trials Logo

Benzodiazepine Abuse clinical trials

View clinical trials related to Benzodiazepine Abuse.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05006079 Recruiting - Opioid Abuse Clinical Trials

Opioid/Benzodiazepine Polydrug Abuse: Aim 3

MAP
Start date: March 13, 2024
Phase: Phase 2
Study type: Interventional

In this study, the investigators will measure affective, neurocognitive and behavioral outcomes related to chronic use of opioids and benzodiazepines (screening phase), and in response to the administration of the opioid morphine, the benzodiazepine alprazolam, morphine then alprazolam, alprazolam then morphine, morphine+alprazolam simultaneously, and placebo (laboratory pharmacology experiment). The latter will enable the investigators to assess the effects of an opioid alone, benzodiazepine alone, concurrent and simultaneous administration of opioid+benzodiazepine, relative to a placebo control.